Proton pump inhibitor therapy usage and associated hospitalization rates and critical care outcomes of COVID-19 patients

Proton Pump Inhibitors (PPI) are one of the most prescribed medications in the United States. However, PPIs have been shown to increase the risk of enteric infections. Our study aims to evaluate the correlation between PPI and COVID-19 severity. We performed a retrospective cohort study on patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Shupp, Brittney, Mehta, Sagar V., Chirayath, Subin, Patel, Nishit, Aiad, Mina, Sapin, Jared, Stoltzfus, Jill, Schneider, Yecheskel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9084256/
https://www.ncbi.nlm.nih.gov/pubmed/35534666
http://dx.doi.org/10.1038/s41598-022-11680-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9084256/
https://www.ncbi.nlm.nih.gov/pubmed/35534666
http://dx.doi.org/10.1038/s41598-022-11680-0

Ejemplares similares